InvestorsHub Logo
Followers 1
Posts 703
Boards Moderated 0
Alias Born 02/06/2009

Re: opportunityknocking post# 22075

Monday, 08/31/2009 2:17:19 PM

Monday, August 31, 2009 2:17:19 PM

Post# of 30387
I disagree: If the market cataclysm had not taken place, Abbott had taken the product to commercialization and Inverness had made public their intentions to commercialize RECAF and as a consequence BOCX price was $3 you would NOT be complaining about the Smithline deal or anything else, for that matter.

Moro had nothing to do with Abbott not having taken RECAF to the market yet. He cannot tell them what to do, can he? He cannot force Inverness to release information, or breach the confidentiality terms of the contract he signed with them, can he?

You stated: <a CEO that could close some deals instead of negotiating till the technology is obsolete.>

I was under the impression that it was Moro who closed the deal with Abbott, the largest diagnostic company on the planet, and as a consequence of that, the price moved from about $0.50 to over $2. Did many shareholders complain then?

I was also under the impression that it was Moro who closed the deal with Inverness, the largest manufacturer of rapid tests on the planet. How many people complained about that?

Were those deals closed by somebody else? Who?
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.